Africa CDC Deploy Experts to Investigate unknown Disease X outbreak in Democratic Republic of Congo
On Dec. 9, 2024, the Africa Centers for Disease Control (CDC) announced that it is working closely with…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Life Science News | NIH | Vaccine
Wuhan lab samples hold no close relatives to virus behind COVID
On Dec. 6, 2024, Shi Zhengli, the Chinese virologist at centre of COVID lab-leak theory, has presented evidence…
Biotechnology | COVID-19 | Life Science News | Medical Device | Medicine | Pharmaceutical | Therapeutics | Vaccine
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, survey data from the Annenberg Public Policy Center (APPC) found that the number of…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CDC reported COVID-19 at highest level in two years
On Aug. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 infections are…
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 8, the World Health Organization (WHO) announced results of a study that showed the introduction of…
Anixa Biosciences and MolGenie announced early potency analysis of SARS-CoV-2 protease inhibitor
On Jan. 24, 2022, Anixa Biosciences announced that the company and its partner, MolGenie, had synthesized a compound…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Study confirmed virus variants reduce protection against COVID-19
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study from found that blood…
Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variant
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
Oregon required all captive mink vaccinated against SARS-CoV-2
On May 28, 2021, the Oregon Department of Agriculture (ODA) lifted the quarantine on the Oregon mink farm…
Oregon mink farm cleared from SARS-CoV-2; farm quarantine lifted
On Feb. 11, 2021, the Oregon Department of Agriculture (ODA) lifted the quarantine on the Oregon mink farm…
OHSU study revealed SARS-CoV-2 reacted to antibodies of virus from 2003 SARS outbreak
On Jan. 25, 2021, Oregon Health & Science University (OHSU) announced a new study demonstrated that antibodies generated…
Anixa Biosciences Covid-19 therapy demonstrated comparable potency to remdesivir in pre-clinical testing
On Dec. 14, 2020, Anixa Biosciences announced that it and partner OntoChem GmbH had verified that one of…
Evidence review confirmed CDC guidance about infectivity of novel coronavirus
On Oct. 20, 2020, researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU) reported…
Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
Anixa Biosciences and OntoChem announced completion of initial screening program and identification of additional Covid-19 compounds
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidate
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
Cases of pneumonia detected in Wuhan, China were first reported to the WHO
On Dec. 31, 2019, the World Health Organization (WHO) declared the Coronavirus outbreak a global pandemic. To date,…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Michael Smith Genome Science Centre sequenced the SARS genome
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list
On Mar. 18, 2003, Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list. Persons under quarantine…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | WHO
SARS (Severe Acute Respiratory Syndrome) was first discovered in Asia
On Mar. 6, 2003, the Singapore Ministry of Health (MOH) and the World Health Organization (WHO), announced they…
Severe Acute Respiratory Syndrome (SARS) was recognized
At t he end of February 2003, the World Health Organization (WHO) recognized Severe Acute Respiratory Syndrome (SARS)…
The CDC established the International Health Program Office
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) established the International Health Program Office, now…
Biology | CDC | Diagnostics | Infectious Disease | Life Science History | NIH | Plague | Therapeutics | Vaccine
The CDC opened an expanded maximum containment lab (hot lab) for highly dangerous viruses
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) completed construction of a new hot lab…